Biosimilar/ja: Difference between revisions

Biosimilar/ja
Created page with "{| class="wikitable" |+欧州連合が承認したバイオシミラー |- ! 活性物質 !! 参照商品 !! バイオシミラー医薬品 |- | Adalimumab/ja || Humira || Amgevita, Amsparity, Cyltezo, Halimatoz, Hefiya, Hukyndra, Hulio, Hyrimoz, Idacio, Imraldi, Kromeya, Libmyris, Solymbic, Trudexa, Yuflyma |- | Bevacizumab/ja || Avastin || Abevmy, Alymsys, Aybintio, Equidacent, Mvasi, Onbevzi, Oyavas, Vegzelma, Zirabev |- | Enoxaparin sodium/ja || Clexane..."
Tags: Mobile edit Mobile web edit
Created page with "== アメリカ == {{Anchor|United States}}"
Tags: Mobile edit Mobile web edit
Line 113: Line 113:
|}
|}


<div lang="en" dir="ltr" class="mw-content-ltr">
== アメリカ ==
== United States ==
{{Anchor|United States}}
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
<div lang="en" dir="ltr" class="mw-content-ltr">